Barnett Nina, Kelly Orla
Pharmacy Department, Northwick Park Hospital, Harrow, UK.
Cantillons Solicitors, Cork, Ireland.
Eur J Hosp Pharm. 2017 Jan;24(1):21-25. doi: 10.1136/ejhpharm-2016-000949.
Deprescribing can feel risky: prescribers need to consider the consequence of stopping a medication medicolegally, particularly where there may be a guideline or accepted practice that suggests its use. This review aims to provide reassurance and encouragement to safely deprescribe. Experience suggests that for many patients the prescribing of multiple medicines is the norm. In the right setting and at the right time, deprescribing provides a real opportunity to minimise side effects and unwanted interactions through patient-centred conversations. How does the prescriber stand if they stop a medication for which there is an evidence-based guideline to use it? This review explores the concepts of clinical negligence and informed patient consent in the context of deprescribing. Using examples from UK case law, the review discusses the legal tests which are applied to establish an action based on clinical negligence and lack of informed consent. It describes the recent changes in law which reinforce the importance of providing information focused on what is material to individual patients. The use of prescribing tools to support safe deprescribing and informed consent are also discussed. When deprescribing is undertaken in partnership with patients, supported by the knowledge, skills and experience of both patient and clinicians and the patient's values and preferences based on clinical skill, judgement and evidence-based medicine, law presents no barriers to deprescribing.
开处方者需要从法律角度考虑停用药物的后果,尤其是在可能存在建议使用该药物的指南或公认做法的情况下。本综述旨在提供安心和鼓励,以安全地减药。经验表明,对许多患者来说,同时服用多种药物是常态。在合适的环境和时机,减药通过以患者为中心的沟通,提供了一个真正的机会来尽量减少副作用和不良相互作用。如果开处方者停用一种有循证指南支持使用的药物,他们该如何自处?本综述探讨了减药背景下的临床过失和患者知情同意的概念。通过英国判例法的例子,本综述讨论了用于确立基于临床过失和缺乏知情同意的诉讼的法律测试。它描述了最近的法律变化,这些变化强化了提供关注对个体患者重要信息的重要性。还讨论了使用处方工具来支持安全减药和知情同意。当减药是在与患者合作的情况下进行,得到患者和临床医生的知识、技能和经验以及基于临床技能、判断和循证医学的患者价值观和偏好的支持时,法律不会对减药构成障碍。